Literature DB >> 11514514

Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

L E Desjardin1, L G Hayes, C D Sohaskey, L G Wayne, K D Eisenach.   

Abstract

Among the products that are expressed when Mycobacterium tuberculosis undergoes hypoxic shiftdown to nonreplicating persistence (NRP) is the alpha-crystallin chaperone protein homologue (Acr). This expression coincides with the previously reported appearance of a respiratory type of nitrate reductase activity, the increase in glycine dehydrogenase activity, and the production of a unique antigen, URB-1. In a timed sampling study, using a slowly stirred oxygen depletion culture model, we have demonstrated that the hspX mRNA that codes for Acr protein as well as the protein itself is induced just as the bacilli enter the microaerophilic NRP stage 1 (NRP-1). In contrast to the induction observed for hspX mRNA, levels of 16S rRNA, fbpB mRNA (encoding the 85B alpha antigen), and aroB mRNA (encoding dehydroquinate synthase) demonstrate relatively small to no change upon entering NRP-1. Acr protein was shown to be identical to URB-1 by Western analysis with anti-URB-1 antibody. The fact that antibody to Acr is found in a high percentage of tuberculosis patients suggests that the hypoxic shiftdown of tubercle bacilli to the NRP state that occurs in vitro, resulting in production of the alpha-crystallin protein, occurs in vivo as well. Simultaneous abrupt increases in hspX mRNA and Acr protein suggest that Acr protein expression is controlled at the level of transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514514      PMCID: PMC95413          DOI: 10.1128/JB.183.18.5311-5316.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

3.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

Authors:  L G Wayne; L G Hayes
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis.

Authors:  L G Wayne; L G Hayes
Journal:  Tuber Lung Dis       Date:  1998

5.  Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

Authors:  L G Wayne; G A Diaz
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

6.  Characterization of the major membrane protein of virulent Mycobacterium tuberculosis.

Authors:  B Y Lee; S A Hefta; P J Brennan
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 7.  Nonreplicating persistence of mycobacterium tuberculosis.

Authors:  L G Wayne; C D Sohaskey
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

8.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

9.  Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions.

Authors:  L G Wayne; K Y Lin
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  The Mycobacterium tuberculosis shikimate pathway genes: evolutionary relationship between biosynthetic and catabolic 3-dehydroquinases.

Authors:  T Garbe; S Servos; A Hawkins; G Dimitriadis; D Young; G Dougan; I Charles
Journal:  Mol Gen Genet       Date:  1991-09
View more
  32 in total

1.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

2.  Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis.

Authors:  JoAnn M Tufariello; Kaixia Mi; Jiayong Xu; Yukari C Manabe; Anup K Kesavan; Joshua Drumm; Kathryn Tanaka; William R Jacobs; John Chan
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Carbon flux rerouting during Mycobacterium tuberculosis growth arrest.

Authors:  Lanbo Shi; Charles D Sohaskey; Carmen Pheiffer; Carmen Pfeiffer; Pratik Datta; Michael Parks; Johnjoe McFadden; Robert J North; Maria L Gennaro
Journal:  Mol Microbiol       Date:  2010-10-06       Impact factor: 3.501

4.  The proteome of Shigella flexneri 2a 2457T grown at 30 and 37 degrees C.

Authors:  Li Zhu; Ge Zhao; Robert Stein; Xuexue Zheng; Wei Hu; Na Shang; Xin Bu; Xiankai Liu; Jie Wang; Erling Feng; Bin Wang; Xuemin Zhang; Qinong Ye; Peitang Huang; Ming Zeng; Hengliang Wang
Journal:  Mol Cell Proteomics       Date:  2010-02-17       Impact factor: 5.911

5.  Different roles of DosS and DosT in the hypoxic adaptation of Mycobacteria.

Authors:  Min-Ju Kim; Kwang-Jin Park; In-Jeong Ko; Young Min Kim; Jeong-Il Oh
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

6.  Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis.

Authors:  Elisabetta Volpe; Giulia Cappelli; Manuela Grassi; Angelo Martino; Annalucia Serafino; Vittorio Colizzi; Nunzia Sanarico; Francesca Mariani
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

7.  ald of Mycobacterium tuberculosis encodes both the alanine dehydrogenase and the putative glycine dehydrogenase.

Authors:  Michelle M Giffin; Lucia Modesti; Ronald W Raab; Lawrence G Wayne; Charles D Sohaskey
Journal:  J Bacteriol       Date:  2011-12-30       Impact factor: 3.490

8.  Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach.

Authors:  Gavin J Ryan; Donald R Hoff; Emily R Driver; Martin I Voskuil; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Dean C Crick; John S Spencer; Anne J Lenaerts
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model.

Authors:  G L Drusano; Nicole Sgambati; Adam Eichas; David L Brown; Robert Kulawy; Arnold Louie
Journal:  MBio       Date:  2010-08-10       Impact factor: 7.867

10.  Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.

Authors:  L Li; C S Mahan; M Palaci; L Horter; L Loeffelholz; J L Johnson; R Dietze; S M Debanne; M L Joloba; A Okwera; W H Boom; K D Eisenach
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.